富国生物医药科技混合型C(011308)申购赎回 |
|
报告期 |
期初总份额(份) |
期末总份额(份) |
期间总申购份额(份) |
期间总赎回份额(份) |
期间净申赎份额(份) |
净申赎比例 |
2024/3/31 |
41,509,100 |
38,320,700 |
8,668,600 |
11,857,100 |
-3,188,500 |
-7.68% |
2023/12/31 |
110,079,000 |
41,509,100 |
85,003,800 |
153,574,000 |
-68,570,200 |
-62.29% |
2023/12/31 |
45,897,900 |
41,509,100 |
4,707,330 |
9,096,060 |
-4,388,730 |
-9.56% |
2023/9/30 |
107,990,000 |
45,897,900 |
8,554,980 |
70,646,900 |
-62,091,920 |
-57.5% |
2023/6/30 |
110,079,000 |
107,990,000 |
71,741,500 |
73,830,500 |
-2,089,000 |
-1.9% |
2023/6/30 |
136,665,000 |
107,990,000 |
17,111,400 |
45,786,900 |
-28,675,500 |
-20.98% |
2023/3/31 |
110,079,000 |
136,665,000 |
54,630,000 |
28,043,600 |
26,586,400 |
24.15% |
2022/12/31 |
45,523,000 |
110,079,000 |
252,562,000 |
188,006,000 |
64,556,000 |
141.81% |
2022/12/31 |
94,875,600 |
110,079,000 |
34,548,700 |
19,345,300 |
15,203,400 |
16.02% |
2022/9/30 |
160,885,000 |
94,875,600 |
63,804,100 |
129,813,000 |
-66,008,900 |
-41.03% |
2022/6/30 |
45,523,000 |
160,885,000 |
154,209,000 |
38,847,100 |
115,361,900 |
253.41% |
2022/6/30 |
67,138,900 |
160,885,000 |
108,695,000 |
14,949,800 |
93,745,200 |
139.63% |
2022/3/31 |
45,523,000 |
67,138,900 |
45,513,300 |
23,897,300 |
21,616,000 |
47.48% |
2021/12/31 |
0 |
45,523,000 |
75,030,900 |
29,507,900 |
45,523,000 |
INF% |
2021/12/31 |
23,711,600 |
45,523,000 |
35,594,900 |
13,783,500 |
21,811,400 |
91.99% |
2021/9/30 |
10,057,700 |
23,711,600 |
22,967,200 |
9,313,380 |
13,653,820 |
135.75% |
2021/6/30 |
0 |
10,057,700 |
16,468,800 |
6,411,070 |
10,057,730 |
INF% |
2021/6/30 |
4,898,570 |
10,057,700 |
10,647,000 |
5,487,850 |
5,159,150 |
105.32% |
2021/3/31 |
0 |
4,898,570 |
5,821,790 |
923,219 |
4,898,571 |
INF% |
*注:新浪财经提醒:以上数据由合作伙伴提供,仅供参考,交易请以正式公告数据为准。